ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ).

Vittorio Fusco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.